Rising and Falling Trends in the Use of Chemotherapy and Targeted Therapy Near the End of Life in Older Patients With Cancer Patients with stage IA to IIA HL and no mediastinal bulk underwent PET ...

Impact of somatic genomic alterations in patients with metastatic colorectal cancer in a minority-rich academic medical center.

Controversial aspects of the regulatory framework for compounding drug products used in positron emission tomography (PET) are discussed. The Food and Drug Administration Modernization Act of 1997 ...

PET is able to recognize when a bone injury is severe enough that resting is indicated to prevent breakdown, but PET also allows monitoring over time to adjust the training and racing programs ...

TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a ...

Fact checked by Nick Blackmer Medically reviewed by Nicholas R. Metrus, MD There is no single way to diagnose Alzheimer's disease. Testing usually includes cognitive assessments, imaging tests like ...

SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small ...

The collaboration is anticipated to find new clinical pathways and aid in improving patient outcomes via imaging solutions.

SAN DIEGO, June 25, 2025--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for ...